Yahoo Web Search

  1. Ads

    related to: neuroscience

Search results

    • This Unpopular Dividend Stock Is a Buy

      This Unpopular Dividend Stock Is a Buy

      The Motley Fool via AOL· 8 hours ago

      In March, for example, the pharma giant completed its acquisition of Karuna Therapeutics, adding the potential blockbuster schizophrenia treatment KarXT...